These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 19628500

  • 1. The effects of ranibizumab (Lucentis) on retinal function in isolated perfused vertebrate retina.
    Lüke M, Januschowski K, Lüke J, Peters S, Wirtz N, Yörük E, Lüke C, Bartz-Schmidt KU, Grisanti S, Szurman P.
    Br J Ophthalmol; 2009 Oct; 93(10):1396-400. PubMed ID: 19628500
    [Abstract] [Full Text] [Related]

  • 2. The effects of triamcinolone crystals on retinal function in a model of isolated perfused vertebrate retina.
    Lüke M, Januschowski K, Beutel J, Warga M, Grisanti S, Peters S, Schneider T, Lüke C, Bartz-Schmidt KU, Szurman P.
    Exp Eye Res; 2008 Jul; 87(1):22-9. PubMed ID: 18514644
    [Abstract] [Full Text] [Related]

  • 3. Effects of bevacizumab on retinal function in isolated vertebrate retina.
    Lüke M, Warga M, Ziemssen F, Gelisken F, Grisanti S, Schneider T, Lüke C, Partsch M, Bartz-Schmidt KU, Szurman P, Tuebingen Bevacizumab Study Group.
    Br J Ophthalmol; 2006 Sep; 90(9):1178-82. PubMed ID: 16754646
    [Abstract] [Full Text] [Related]

  • 4. Electrophysiological toxicity testing of VEGF Trap-Eye in an isolated perfused vertebrate retina organ culture model.
    Januschowski K, Schnichels S, Hagemann U, Koch V, Hofmann J, Spitzer MS, Bartz-Schmidt KU, Szurman P, Lüke M, Aisenbrey S.
    Acta Ophthalmol; 2014 Jun; 92(4):e305-11. PubMed ID: 24206925
    [Abstract] [Full Text] [Related]

  • 5. The retinal tolerance to bevacizumab in co-application with a recombinant tissue plasminogen activator.
    Lüke M, Januschowski K, Warga M, Beutel J, Leitritz M, Gelisken F, Grisanti S, Schneider T, Lüke C, Bartz-Schmidt KU, Szurman P, Tuebingen Bevacizumab Study Group.
    Br J Ophthalmol; 2007 Aug; 91(8):1077-82. PubMed ID: 17383998
    [Abstract] [Full Text] [Related]

  • 6. Intravitreal ranibizumab may induce retinal arteriolar vasoconstriction in patients with neovascular age-related macular degeneration.
    Papadopoulou DN, Mendrinos E, Mangioris G, Donati G, Pournaras CJ.
    Ophthalmology; 2009 Sep; 116(9):1755-61. PubMed ID: 19560206
    [Abstract] [Full Text] [Related]

  • 7. Effects of pegaptanib sodium on retinal function in isolated perfused vertebrate retina.
    Lüke M, Januschowski K, Tura A, Lüke J, Nassar K, Lüke C, Schneider T, Szurman P, Grisanti S, Bartz-Schmidt KU.
    Curr Eye Res; 2010 Mar; 35(3):248-54. PubMed ID: 20373885
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Ranibizumab inhibits multiple forms of biologically active vascular endothelial growth factor in vitro and in vivo.
    Lowe J, Araujo J, Yang J, Reich M, Oldendorp A, Shiu V, Quarmby V, Lowman H, Lien S, Gaudreault J, Maia M.
    Exp Eye Res; 2007 Oct; 85(4):425-30. PubMed ID: 17714704
    [Abstract] [Full Text] [Related]

  • 10. Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab.
    Funk M, Karl D, Georgopoulos M, Benesch T, Sacu S, Polak K, Zlabinger GJ, Schmidt-Erfurth U.
    Ophthalmology; 2009 Dec; 116(12):2393-9. PubMed ID: 19815292
    [Abstract] [Full Text] [Related]

  • 11. VEGF-induced effects on proliferation, migration and tight junctions are restored by ranibizumab (Lucentis) in microvascular retinal endothelial cells.
    Deissler H, Deissler H, Lang S, Lang GE.
    Br J Ophthalmol; 2008 Jun; 92(6):839-43. PubMed ID: 18511543
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics and retinal distribution of ranibizumab, a humanized antibody fragment directed against VEGF-A, following intravitreal administration in rabbits.
    Gaudreault J, Fei D, Beyer JC, Ryan A, Rangell L, Shiu V, Damico LA.
    Retina; 2007 Jun; 27(9):1260-6. PubMed ID: 18046235
    [Abstract] [Full Text] [Related]

  • 13. Comparing the effects of two different irrigation solutions on an isolated perfused vertebrate retina.
    Januschowski K, Maddani R, Mueller S, Lueke M, Spitzer MS, Schultheiss M, Bartz-Schmidt KU, Szurman P.
    Ophthalmic Res; 2012 Jun; 48(2):59-66. PubMed ID: 22472946
    [Abstract] [Full Text] [Related]

  • 14. Effects of protein tyrosine kinase inhibitor genistein on retinal function in superfused vertebrate retina.
    Lüke C, Krott R, Lüke M, Lebek J, Walter P, Brunner R, Sickel W.
    J Ocul Pharmacol Ther; 2001 Apr; 17(2):151-8. PubMed ID: 11324982
    [Abstract] [Full Text] [Related]

  • 15. The isolated perfused bovine retina--a sensitive tool for pharmacological research on retinal function.
    Lüke M, Weiergräber M, Brand C, Siapich SA, Banat M, Hescheler J, Lüke C, Schneider T.
    Brain Res Brain Res Protoc; 2005 Dec; 16(1-3):27-36. PubMed ID: 16275053
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The concentration-dependent effects of indocyanine green on retinal function in the electrophysiological ex vivo model of isolated perfused vertebrate retina.
    Ranjbar M, Alt A, Nassar K, Reinsberg M, Schneider T, Grisanti S, Lüke J, Lüke M.
    Ophthalmic Res; 2014 Dec; 51(3):167-71. PubMed ID: 24642512
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.